These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 28757251)

  • 1. The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a.
    Liu L; Li X; Ma J; Li Z; You L; Wang J; Wang M; Zhang X; Wang Y
    Cell; 2017 Aug; 170(4):714-726.e10. PubMed ID: 28757251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for self-cleavage prevention by tag:anti-tag pairing complementarity in type VI Cas13 CRISPR systems.
    Wang B; Zhang T; Yin J; Yu Y; Xu W; Ding J; Patel DJ; Yang H
    Mol Cell; 2021 Mar; 81(5):1100-1115.e5. PubMed ID: 33472057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Distant Catalytic Sites Are Responsible for C2c2 RNase Activities.
    Liu L; Li X; Wang J; Wang M; Chen P; Yin M; Li J; Sheng G; Wang Y
    Cell; 2017 Jan; 168(1-2):121-134.e12. PubMed ID: 28086085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
    Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
    Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guide-bound structures of an RNA-targeting A-cleaving CRISPR-Cas13a enzyme.
    Knott GJ; East-Seletsky A; Cofsky JC; Holton JM; Charles E; O'Connell MR; Doudna JA
    Nat Struct Mol Biol; 2017 Oct; 24(10):825-833. PubMed ID: 28892041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA Targeting by Functionally Orthogonal Type VI-A CRISPR-Cas Enzymes.
    East-Seletsky A; O'Connell MR; Burstein D; Knott GJ; Doudna JA
    Mol Cell; 2017 May; 66(3):373-383.e3. PubMed ID: 28475872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryo-EM structure of the RNA-guided ribonuclease Cas12g.
    Li Z; Zhang H; Xiao R; Han R; Chang L
    Nat Chem Biol; 2021 Apr; 17(4):387-393. PubMed ID: 33495647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The crystal structure of Cpf1 in complex with CRISPR RNA.
    Dong D; Ren K; Qiu X; Zheng J; Guo M; Guan X; Liu H; Li N; Zhang B; Yang D; Ma C; Wang S; Wu D; Ma Y; Fan S; Wang J; Gao N; Huang Z
    Nature; 2016 Apr; 532(7600):522-6. PubMed ID: 27096363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection.
    East-Seletsky A; O'Connell MR; Knight SC; Burstein D; Cate JH; Tjian R; Doudna JA
    Nature; 2016 Oct; 538(7624):270-273. PubMed ID: 27669025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Basis for the Ribonuclease Activity of a Thermostable CRISPR-Cas13a from Thermoclostridium caenicola.
    Wang F; Zhang C; Xu H; Zeng W; Ma L; Li Z
    J Mol Biol; 2023 Sep; 435(17):168197. PubMed ID: 37442412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cas13d Is a Compact RNA-Targeting Type VI CRISPR Effector Positively Modulated by a WYL-Domain-Containing Accessory Protein.
    Yan WX; Chong S; Zhang H; Makarova KS; Koonin EV; Cheng DR; Scott DA
    Mol Cell; 2018 Apr; 70(2):327-339.e5. PubMed ID: 29551514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a.
    Tambe A; East-Seletsky A; Knott GJ; Doudna JA; O'Connell MR
    Cell Rep; 2018 Jul; 24(4):1025-1036. PubMed ID: 30044970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure Reveals a Mechanism of CRISPR-RNA-Guided Nuclease Recruitment and Anti-CRISPR Viral Mimicry.
    Rollins MF; Chowdhury S; Carter J; Golden SM; Miettinen HM; Santiago-Frangos A; Faith D; Lawrence CM; Lander GC; Wiedenheft B
    Mol Cell; 2019 Apr; 74(1):132-142.e5. PubMed ID: 30872121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two HEPN domains dictate CRISPR RNA maturation and target cleavage in Cas13d.
    Zhang B; Ye Y; Ye W; Perčulija V; Jiang H; Chen Y; Li Y; Chen J; Lin J; Wang S; Chen Q; Han YS; Ouyang S
    Nat Commun; 2019 Jun; 10(1):2544. PubMed ID: 31186424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
    O'Connell MR
    J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure Studies of the CRISPR-Csm Complex Reveal Mechanism of Co-transcriptional Interference.
    You L; Ma J; Wang J; Artamonova D; Wang M; Liu L; Xiang H; Severinov K; Zhang X; Wang Y
    Cell; 2019 Jan; 176(1-2):239-253.e16. PubMed ID: 30503210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. tRNA anticodon cleavage by target-activated CRISPR-Cas13a effector.
    Jain I; Kolesnik M; Kuznedelov K; Minakhin L; Morozova N; Shiriaeva A; Kirillov A; Medvedeva S; Livenskyi A; Kazieva L; Makarova KS; Koonin EV; Borukhov S; Severinov K; Semenova E
    Sci Adv; 2024 Apr; 10(17):eadl0164. PubMed ID: 38657076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C2c1-sgRNA Complex Structure Reveals RNA-Guided DNA Cleavage Mechanism.
    Liu L; Chen P; Wang M; Li X; Wang J; Yin M; Wang Y
    Mol Cell; 2017 Jan; 65(2):310-322. PubMed ID: 27989439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.
    Jia N; Mo CY; Wang C; Eng ET; Marraffini LA; Patel DJ
    Mol Cell; 2019 Jan; 73(2):264-277.e5. PubMed ID: 30503773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving trans-cleavage activity of CRISPR-Cas13a using engineered crRNA with a uridinylate-rich 5'-overhang.
    Yang Y; Sun L; Zhao J; Jiao Y; Han T; Zhou X
    Biosens Bioelectron; 2024 Jul; 255():116239. PubMed ID: 38552526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.